GE HealthCare (GEHC) announced an expanded collaboration with DeepHealth, a player in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (RDNT), to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and women’s health. “At GE HealthCare, we’re advancing women’s health through precision care built around the unique needs of women and enhanced by the power of AI,” said Jyoti Gupta, PhD, President and CEO, Women’s Health and X-ray at GE HealthCare. “By integrating Breast Suite AI with our Pristina Via(TM) mammography system, we’re helping clinicians detect breast cancer early with greater confidence. These innovations move us closer towards truly personalized prevention and care for women.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare price target lowered to $90 from $95 at Mizuho
- GE HealthCare price target lowered to $85 from $91 at BTIG
- GE HealthCare announces digital integration between bkActik, AXiS
- GE HealthCare price target lowered to $80 from $84 at Citi
- GE HealthCare price target lowered to $85 from $98 at Evercore ISI
